Annual Revenue
$56.19 M
+$3.90 M+7.46%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual revenue is $56.19 million, with the most recent change of +$3.90 million (+7.46%) on December 31, 2023.
- During the last 3 years, IPHA annual revenue has fallen by -$7.94 million (-12.38%).
- IPHA annual revenue is now -40.44% below its all-time high of $94.34 million, reached on December 31, 2018.
Performance
IPHA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
June 30, 2024
Summary
- IPHA quarterly revenue is not available.
Performance
IPHA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
June 30, 2024
Summary
- IPHA TTM revenue is not available.
Performance
IPHA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
IPHA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.5% | - | - |
| 3 y3 years | -12.4% | - | - |
| 5 y5 years | -40.4% | - | - |
IPHA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +292.1% | ||||
| 5 y | 5-year | -26.8% | +292.1% | ||||
| alltime | all time | -40.4% | +4558.3% |
Innate Pharma SA Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $56.19 M(+7.5%) | - | - |
| Dec 2022 | $52.29 M(+264.9%) | - | - |
| Dec 2021 | $14.33 M(-77.7%) | - | - |
| Apr 2021 | - | $261.10 M(+6.2%) | $1.07 B(-0.1%) |
| Jan 2021 | - | $245.93 M(-9.5%) | $1.07 B(+2.2%) |
| Dec 2020 | $64.13 M(-16.5%) | - | - |
| Oct 2020 | - | $271.81 M(-7.3%) | $1.05 B(+2.0%) |
| Jul 2020 | - | $293.37 M(+11.8%) | $1.03 B(+3.0%) |
| Apr 2020 | - | $262.40 M(+17.8%) | $1.00 B(+2.3%) |
| Jan 2020 | - | $222.81 M(-11.4%) | $977.91 M(+0.2%) |
| Dec 2019 | $76.81 M(-18.6%) | - | - |
| Oct 2019 | - | $251.61 M(-4.5%) | $975.99 M(-0.9%) |
| Jul 2019 | - | $263.57 M(+9.9%) | $985.08 M(-2.9%) |
| Apr 2019 | - | $239.91 M(+8.6%) | $1.01 B(+31.0%) |
| Jan 2019 | - | $220.89 M | $774.19 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $94.34 M(+155.3%) | - | - |
| Oct 2018 | - | $260.71 M(-10.9%) | $553.30 M(+89.1%) |
| Jul 2018 | - | $292.59 M | $292.59 M |
| Dec 2017 | $36.95 M(-40.5%) | - | - |
| Dec 2016 | $62.16 M(+212.8%) | - | - |
| Dec 2015 | $19.87 M(+1547.3%) | - | - |
| Dec 2014 | $1.21 M(-92.7%) | - | - |
| Dec 2013 | $16.56 M(+24.1%) | - | - |
| Dec 2012 | $13.34 M(+28.4%) | - | - |
| Dec 2011 | $10.39 M(+81.5%) | - | - |
| Dec 2010 | $5.73 M(-46.8%) | - | - |
| Dec 2009 | $10.76 M(-43.3%) | - | - |
| Dec 2008 | $18.97 M(-3.2%) | - | - |
| Dec 2007 | $19.59 M(+83.9%) | - | - |
| Dec 2006 | $10.65 M(+250.2%) | - | - |
| Dec 2005 | $3.04 M | - | - |
FAQ
- What is Innate Pharma SA annual revenue?
- What is the all time high annual revenue for Innate Pharma SA?
- What is Innate Pharma SA annual revenue year-on-year change?
- What is the all time high quarterly revenue for Innate Pharma SA?
- What is the all time high TTM revenue for Innate Pharma SA?
What is Innate Pharma SA annual revenue?
The current annual revenue of IPHA is $56.19 M
What is the all time high annual revenue for Innate Pharma SA?
Innate Pharma SA all-time high annual revenue is $94.34 M
What is Innate Pharma SA annual revenue year-on-year change?
Over the past year, IPHA annual revenue has changed by +$3.90 M (+7.46%)
What is the all time high quarterly revenue for Innate Pharma SA?
Innate Pharma SA all-time high quarterly revenue is $293.37 M
What is the all time high TTM revenue for Innate Pharma SA?
Innate Pharma SA all-time high TTM revenue is $1.07 B